Literature DB >> 21917746

Scientific frontiers: emerging technologies for salivary diagnostics.

B J Baum1, J R Yates, S Srivastava, D T W Wong, J E Melvin.   

Abstract

Saliva, a biofluid historically well-studied biochemically and physiologically, has entered the post-genomic 'omics' era, where its proteomic, genomic, and microbiome constituents have been comprehensively deciphered. The translational path of these salivary constituents has begun toward a variety of personalized individual medical applications, including early detection of cancer. Salivary diagnostics is a late-comer, but it is catching up where dedicated resources, like the Salivaomics Knowledge Base (SKB), now have taken center stage in the dissemination of the diagnostic potentials of salivary biomarkers and other translational and clinical utilities. © International & American Associations for Dental Research

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917746      PMCID: PMC3172997          DOI: 10.1177/0022034511420433

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  59 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility.

Authors:  Rui Vitorino; Sofia de Morais Guedes; Rita Ferreira; Maria João C Lobo; José Duarte; António J Ferrer-Correia; Kenneth B Tomer; Pedro M Domingues; Francisco M L Amado
Journal:  Eur J Oral Sci       Date:  2006-04       Impact factor: 2.612

Review 3.  Dystrophin abnormalities in Duchenne/Becker muscular dystrophy.

Authors:  E P Hoffman; L M Kunkel
Journal:  Neuron       Date:  1989-01       Impact factor: 17.173

4.  Identification and characterization of a nonimmunoglobulin factor in human saliva that inhibits Streptococcus mutans glucosyltransferase.

Authors:  Christina Jespersgaard; George Hajishengallis; Michael W Russell; Suzanne M Michalek
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.

Authors:  Lei Zhang; James J Farrell; Hui Zhou; David Elashoff; David Akin; No-Hee Park; David Chia; David T Wong
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

6.  Cross-sectional and longitudinal analyses of stimulated parotid salivary constituents in healthy, different-aged subjects.

Authors:  A J Wu; J C Atkinson; P C Fox; B J Baum; J A Ship
Journal:  J Gerontol       Date:  1993-09

7.  Sodium handling by aging human parotid glands is inconsistent with a two-stage secretion model.

Authors:  B J Baum; P T Costa; K T Izutsu
Journal:  Am J Physiol       Date:  1984-01

8.  Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma.

Authors:  Hiroichi Kobayashi; Junji Sagara; Hiroshi Kurita; Masayo Morifuji; Masamichi Ohishi; Kenji Kurashina; Shun'ichiro Taniguchi
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

9.  Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease.

Authors:  K A Brogden; M Heidari; R E Sacco; D Palmquist; J M Guthmiller; G K Johnson; H P Jia; B F Tack; P B McCray
Journal:  Oral Microbiol Immunol       Date:  2003-04

10.  Expression of the DMBT1 gene is frequently suppressed in human lung cancer.

Authors:  H Takeshita; M Sato; H O Shiwaku; S Semba; A Sakurada; M Hoshi; Y Hayashi; Y Tagawa; H Ayabe; A Horii
Journal:  Jpn J Cancer Res       Date:  1999-09
View more
  25 in total

1.  The PBRN initiative: transforming new technologies to improve patient care.

Authors:  F A Curro; D Vena; F Naftolin; L Terracio; V P Thompson
Journal:  J Dent Res       Date:  2012-07       Impact factor: 6.116

Review 2.  Great expectorations: the potential of salivary 'omic' approaches in neonatal intensive care.

Authors:  J Romano-Keeler; J L Wynn; J L Maron
Journal:  J Perinatol       Date:  2014-01-09       Impact factor: 2.521

3.  Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model.

Authors:  Joseph D Foley; J Darrell Sneed; Steven R Steinhubl; Justin R Kolasa; Jeffrey L Ebersole; Yushun Lin; Richard J Kryscio; John T McDevitt; Charles L Campbell; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-09-28

Review 4.  The scientific exploration of saliva in the post-proteomic era: from database back to basic function.

Authors:  Stefan Ruhl
Journal:  Expert Rev Proteomics       Date:  2012       Impact factor: 3.940

Review 5.  Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics.

Authors:  David T W Wong
Journal:  Clin Ther       Date:  2015-03-18       Impact factor: 3.393

6.  Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance.

Authors:  Gauri S Desai; Suresh T Mathews
Journal:  World J Diabetes       Date:  2014-12-15

Review 7.  Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

Authors:  J W Mays; H Fassil; D A Edwards; S Z Pavletic; C W Bassim
Journal:  Oral Dis       Date:  2012-10-28       Impact factor: 3.511

8.  Degree of Agreement Between Infant Serum and Salivary Concentration of Leptin and Adiponectin and Its Association With Infants' Feeding.

Authors:  Ana M Linares; Mary Kay Rayens; Jennifer S Moylan; Craig S Miller
Journal:  Biol Res Nurs       Date:  2020-11-28       Impact factor: 2.318

Review 9.  Non-coding RNAs in saliva: emerging biomarkers for molecular diagnostics.

Authors:  Blanca Majem; Marina Rigau; Jaume Reventós; David T Wong
Journal:  Int J Mol Sci       Date:  2015-04-17       Impact factor: 5.923

10.  Cross-translational studies in human and Drosophila identify markers of sleep loss.

Authors:  Matthew S Thimgan; Laura Gottschalk; Cristina Toedebusch; Jennifer McLeland; Allan Rechtschaffen; Marcia Gilliland-Roberts; Stephen P Duntley; Paul J Shaw
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.